ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,370Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 298

$617K Total Retail Price of All Prescriptions

Rank: 14 out of 298

561 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 12,586 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 563 534 1 3
WARFARIN SODIUM 561 552 2 7
METOPROLOL SUCCINATE 547 539 3 12
SIMVASTATIN 452 385 4 2
AMLODIPINE BESYLATE 450 442 5 6
FUROSEMIDE 447 420 6 5
LEVOTHYROXINE SODIUM 416 394 7 1
HYDROCODONE-ACETAMINOPHEN 353 318 S3 8 8
ATORVASTATIN CALCIUM 278 264 9 14
CARVEDILOL 270 270 10 23
BENAZEPRIL HCL 257 245 11 52
METOPROLOL TARTRATE 246 225 12 9
HYDROCHLOROTHIAZIDE 237 220 13 13
POLYETHYLENE GLYCOL 3350 223 217 14 29
ATENOLOL 220 206 15 16
ALENDRONATE SODIUM 216 202 16 21
METFORMIN HCL 203 176 17 10
LISINOPRIL 184 175 18 4
SERTRALINE HCL 154 154 19 19
TAMSULOSIN HCL 153 153 20 24
DIOVAN 149 149 21 47
PREDNISONE 136 133 22 33
KLOR-CON 10 130 129 23 61
ALLOPURINOL 129 119 24 28
GLIMEPIRIDE 129 118 24 60
TRAMADOL HCL 128 128 26 15
LANTUS 128 128 26 53
DIGOXIN 120 111 28 27
MIRTAZAPINE 113 113 29 37
GEMFIBROZIL 108 107 30 65
CIPROFLOXACIN HCL 105 101 31 56
ZOLPIDEM TARTRATE 103 87 32 25
CARBIDOPA-LEVODOPA 99 99 33 49
CITALOPRAM HBR 94 70 34 17
NAMENDA 92 92 35 35
ALBUTEROL SULFATE 89 87 36 75
ADVAIR DISKUS 89 78 36 46
TRIAMCINOLONE ACETONIDE 85 83 38 123
POTASSIUM CHLORIDE 83 83 39 11
PAROXETINE HCL 82 75 40 48
CLOPIDOGREL 81 81 41 36
EXELON 77 77 42 132
RANITIDINE HCL 76 52 43 59
LIPITOR 74 69 44 125
NAPROXEN 72 70 45 148
CEPHALEXIN 70 65 46 94
PLAVIX 68 68 47 70
CEFPROZIL 67 56 48 188
FENTANYL 64 64 S2 49 32
KLOR-CON M20 62 62 50 78
INSULIN SYRINGE 61 61 51 99
IRBESARTAN 59 59 52 220
BUDESONIDE 58 58 53 168
LEVOFLOXACIN 58 49 53 101
TRIAMTERENE-HCTZ 58 58 53 43
ENALAPRIL MALEATE 56 44 56 58
NEXIUM 54 50 57 40
ISOSORBIDE MONONITRATE ER 53 53 58 45
LOSARTAN POTASSIUM 52 48 59 18
NOVOLIN R 51 51 60 195
KLOR-CON M10 51 50 60 180
MUPIROCIN 51 49 60 180
FLUOXETINE HCL 50 50 63 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.